In a nutshell This study investigated the impact of white blood cell counts on the outcomes of newly diagnosed Hodgkin’s lymphoma (HL) patients receiving treatment mediated by PET2 (PET scanning after 2 cycles of chemotherapy). This study concluded that ratios of different types of white blood cells combined with PET2 can be a meaningful...
Read MoreTreatment(s) now being considered-Chemotherapy Posts on Medivizor
Does PET/CT scanning after one ABVD cycle better predict treatment outcomes than scanning after two cycles (iPET2)?
In a nutshell This study analyzed PET/CT scans from new Hodgkin’s lymphoma patients after one (iPET1) or two (iPET2) cycles of ABVD chemotherapy. The study concluded that iPET2 is better than iPET1 at predicting ABVD outcomes in HL patients. Some background Interem PET/CT scanning is used to guide early treatment for new Hodgkin’s...
Read MoreWhat are the outcomes for early-stage HL patients treated with ABVD and radiotherapy alone?
In a nutshell This study determined the outcomes of early-stage classical Hodgkin’s lymphoma (HL) patients who received ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) chemotherapy and radiotherapy (RT) only. The study concluded that patients who showed a good partial response (tumor shrinkage) to ABVD chemotherapy were successfully...
Read MoreOxaliplatin in the treatment of colorectal cancer in elderly patients
In a nutshell This study investigated the safety of oxaliplatin to treat colorectal cancer in elderly patients. Researchers suggested that oxaliplatin treatment is associated with neuropathy (numbness of arms or legs) in these patients. Some background Colorectal cancer is one of the most common forms of cancer among the elderly....
Read MoreHow safe and effective is combined brentuximab vedotin and bendamustine in patients with relapsed/refractory HL?
In a nutshell This study determined the safety and effectiveness of combined brentuximab vedotin (Adcetris) and bendamustine (Treanda) for relapsed or refractory (did not respond to treatment) Hodgkin’s lymphoma (HL). The study concluded that this combination is safe and effective, even for patients who already received intense anticancer...
Read MoreFOLFOXIRI is associated with improved treatment outcomes in metastatic colorectal cancer patients
In a nutshell This study investigated the effectiveness of the chemotherapy FOLFOXIRI as treatment for colorectal cancer. Researchers suggested that this chemotherapy is associated with improved treatment outcomes. Some background Chemotherapy is used in cancer patients to reduce symptoms and prolong survival. Chemotherapy drugs attack cancer...
Read MoreEarly outcomes of proton therapy after chemotherapy
In a nutshell This study examined outcomes for patients with Hodgkin lymphoma receiving chemotherapy followed by proton therapy. Researchers reported good disease control and a low rate of side effects at 3 years. However, continued follow-up is needed. Some background The combination of chemotherapy and radiation therapy provides the best...
Read MoreDoes Tibetan yoga help with fatigue during chemotherapy for breast cancer?
In a nutshell This study examined whether practicing Tibetan yoga during chemotherapy can benefit sleep quality. This study concluded that practicing twice a week or more led to greater long-term benefits over time. Some background Sleep disturbances and fatigue are common side effects reported by patients undergoing chemotherapy. This can...
Read MorePost-surgery complications can affect chemotherapy treatment after surgery in colorectal cancer
In a nutshell This study investigated the post-surgery factors that affect the use of chemotherapy after surgery in colorectal cancer patients. Researchers suggested that post-surgery complications are associated with delay or not receiving chemotherapy treatment. Some background Surgery and post-surgery chemotherapy are the standard...
Read MoreASCO 2017: Updates on Small Cell Lung Cancer Treatment and Research
Video information: At the 2017 ASCO meeting in Chicago, Dr. George Simon and Dr. David Carbone talk about news and progress in small cell lung cancer. Dr. Simon goes into detail on some new promising approaches and current studies for small cell lung cancer treatment, adding "these are some of the newer, in my opinion, more exciting approaches...
Read MoreA review of chemotherapy alone or chemotherapy plus radiation therapy to treat adult patients with Hodgkin lymphoma
In a nutshell This paper is a review of the effectiveness of chemotherapy alone or chemotherapy plus radiotherapy for treating adult patients with early stage Hodgkin lymphoma. The review concluded that, for the same chemotherapy regimen, RT may increase progression free survival, but has little effect on overall survival for patients. Some background...
Read MoreHow safe and effective is chemotherapy given through the limb in elderly melanoma patients?
In a nutshell This study looked at the safety and effectiveness of isolated limb infusion in elderly patients with melanoma of the skin on a limb (arm/leg) that could not be surgically removed. The study found isolated limb infusion to be safe and effective in elderly patients. Some background lsolated limb perfusion (ILP) is a method of...
Read More